S Durmuş, T Çakır, A Özgür, R Guthke - Frontiers in microbiology, 2015 - frontiersin.org
Pathogens manipulate the cellular mechanisms of host organisms via pathogen–host interactions (PHIs) in order to take advantage of the capabilities of host cells, leading to …
N Subramanian, P Torabi‐Parizi… - … Systems Biology and …, 2015 - Wiley Online Library
The mammalian immune system is a dynamic multiscale system composed of a hierarchically organized set of molecular, cellular, and organismal networks that act in …
S Bhushal, M Wolfsmüller, TA Selvakumar… - Frontiers in …, 2017 - frontiersin.org
Type I and type III interferons (IFNs) are crucial components of the first-line antiviral host response. While specific receptors for both IFN types exist, intracellular signaling shares the …
AK Chakraborty - Annual review of immunology, 2017 - annualreviews.org
This is an exciting time for immunology because the future promises to be replete with exciting new discoveries that can be translated to improve health and treat disease in novel …
MW Dobenecker, JK Kim, J Marcello, TC Fang… - Journal of Experimental …, 2015 - rupress.org
The fidelity of T cell immunity depends greatly on coupling T cell receptor signaling with specific T cell effector functions. Here, we describe a chromatin-based mechanism that …
DE Zak, VC Tam, A Aderem - Annual review of immunology, 2014 - annualreviews.org
Systems-level analysis of biological processes strives to comprehensively and quantitatively evaluate the interactions between the relevant molecular components over time, thereby …
GA Poland, JA Whitaker, CM Poland… - Current opinion in …, 2016 - Elsevier
Highlights•Vaccines have eradicated smallpox, nearly eradicated polio, and resulted in 99.9% reduction in incidence rates for many diseases.•There are significant challenges …
SL Cook, MC Franke, EP Sievert, R Sciammas - Trends in immunology, 2020 - cell.com
Control of diverse pathogens requires an adaptive antibody response, dependent on cellular division of labor to allocate antigen-dependent B-and CD4+ T-cell fates that …
Rare ovarian cancers are ovarian cancers with an annual incidence of less than 6 cases per 100,000 women. They generally have a poor prognosis due to being delayed diagnosis and …